# Sleep and Inflammatory Resolution Pathway

> **NCT03377543** · EARLY_PHASE1 · ACTIVE_NOT_RECRUITING · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 66 (estimated)

## Conditions studied

- Inflammatory Response
- Inflammation
- Sleep
- Sleep Restriction

## Interventions

- **DRUG:** Aspirin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03377543
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-06-06
- **Primary completion:** 2025-12-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2025-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03377543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03377543, "Sleep and Inflammatory Resolution Pathway". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03377543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*